Sands Capital Ventures as of Dec. 31, 2022
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 24 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dice Therapeutics | 23.5 | $86M | 2.7M | 31.20 | |
| Uipath Com Cl A (PATH) | 13.3 | $49M | 3.8M | 12.71 | |
| Nu Holdings Com Cl A (NU) | 10.2 | $37M | 9.2M | 4.07 | |
| Samsara Com Cl B | 9.2 | $34M | 2.7M | 12.43 | |
| Snowflake Com Cl A (SNOW) | 8.5 | $31M | 216k | 143.54 | |
| Doordash Com Cl A (DASH) | 8.1 | $30M | 604k | 48.82 | |
| Acrivon Therapeutics (ACRV) | 5.2 | $19M | 1.7M | 11.52 | |
| Acumen Pharmaceuticals (ABOS) | 5.1 | $19M | 3.4M | 5.40 | |
| Olink Hldg Ab (OLK) | 4.9 | $18M | 706k | 25.38 | |
| 10X Genomics Com Cl A (TXG) | 4.8 | $18M | 482k | 36.44 | |
| Karuna Therapeutics Ord | 3.2 | $12M | 59k | 196.50 | |
| Samsara Com Cl A (IOT) | 1.1 | $4.1M | 333k | 12.43 | |
| Tarsus Pharmaceuticals (TARS) | 1.0 | $3.8M | 260k | 14.66 | |
| 908 Devices (MASS) | 0.7 | $2.5M | 326k | 7.62 | |
| Taysha Gene Therapies (TSHA) | 0.4 | $1.6M | 725k | 2.26 | |
| Candel Therapeutics (CADL) | 0.4 | $1.5M | 812k | 1.79 | |
| Spruce Biosciences (SPRB) | 0.2 | $866k | 787k | 1.10 | |
| Absci Corp (ABSI) | 0.0 | $121k | 58k | 2.09 | |
| Coupang (CPNG) | 0.0 | $103k | 7.0k | 14.78 | |
| Datadog Inc Cl A (DDOG) | 0.0 | $100k | 1.4k | 73.21 | |
| Crowdstrike Hldgs Inc cl a (CRWD) | 0.0 | $91k | 864.00 | 105.32 | |
| Toast (TOST) | 0.0 | $81k | 4.5k | 18.02 | |
| Confluent (CFLT) | 0.0 | $30k | 1.4k | 22.16 | |
| Gitlab (GTLB) | 0.0 | $30k | 658.00 | 45.59 |
